BrilliantStrings Therapeutics, Inc.
Developer of an injectable collagen-based mechanotherapeutic platform for repair of connective tissues. The company focuses on delivery of complete human collagen via dense, liquid-crystal formulations intended for targeted, ultrasound-guided injection to treat tendon and rotator cuff injuries. Activities described include foundational research in extracellular matrix mechanochemistry and collagen assembly, proprietary manufacturing and targeting approaches, plans to scale collagen production, and initiation of Phase I clinical trials.
Industries
N/A
Products
Injectable complete human collagen therapeutic for tendon and rotator cuff repair
An injectable formulation of complete human collagen delivered to injury sites to support tendon repair and tissue restoration via targeted, controlled release.
Injectable complete human collagen therapeutic for tendon and rotator cuff repair
An injectable formulation of complete human collagen delivered to injury sites to support tendon repair and tissue restoration via targeted, controlled release.
Expertise Areas
- Biomaterials and collagen-based therapeutics
- Mechanobiology and extracellular matrix research
- Injectable therapeutic delivery for musculoskeletal indications
- Manufacturing scale-up for biologic materials
Key Technologies
- Liquid-crystal biomaterial formulations
- Injectable biomaterial delivery
- Collagen processing and assembly methods
- Extracellular matrix mechanochemistry